American CryoStem Corporation (CRYO)

$0.107

-0.00 (-1.83%)
Rating:
Recommendation:
-
Symbol CRYO
Price $0.107
Beta -0.704
Volume Avg. 0.02M
Market Cap 4.738M
Shares () -
52 Week Range 0.06-0.6
1y Target Est -
DCF Unlevered CRYO DCF ->
DCF Levered CRYO LDCF ->
ROE 219.23% Strong Buy
ROA -359.90% Strong Sell
Operating Margin -
Debt / Equity -156.40% Sell
P/E -
P/B -2.51 Strong Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Anthony Francis Dudzinski Jr.
Healthcare
Biotechnology
Other OTC

American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.